This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The life sciences industry is well positioned for growth in 2025, fueled by strong investor interest and technological advancements, especially in AI. Life sciences venture capital (VC) funding and IPOs have picked up in 2024, and anticipated Federal Reserve interest rate cuts will likely further accelerate this trend.
By Hadeel Al Sayegh, Andres Gonzalez and Federico Maccioni DUBAI/LONDON (Reuters) -Abu Dhabi’s Etihad Airways plans to make its stock market debut no sooner than 2025, two people familiar with the matter said, in potentially the first IPO of a major Gulf airline as the UAE’s capital ramps up effort to become a global travel […]
15, 2025 (GLOBE NEWSWIRE) -- BurTech Acquisition Corp. and began trading on Nasdaq under the ticker symbols BZAI and BZAIW on January 14, 2025. WASHINGTON and EL DORADO HILLS, Calif., BurTech) (NASDAQ: BRKH), a publicly traded special purpose acquisition company, and Blaize, Inc.
The London Stock Exchange (LSEG) saw overall growth across its key businesses in 2023, with considerable improvement across data and analytics, capital markets, and in particular, post-trade. year-on-year increase, while capital markets saw a 6.1% We are also seeing an encouraging IPO pipeline for the London Stock Exchange.
We have not changed our forecast for 2024 and 2025 in terms of deal-volume upticks this year and next. We’ve seen private capital investment banking practices raise substantial funds amid a difficult fundraising environment. Which industries do you see leading the eventual thawing of the M&A and IPO markets?
This results in the target company receiving a potentially very different capital structure than they previously had, typically with higher debt levels. Like a typical leveraged buyout, this can be achieved by selling the company to another private entity or PE firm or taking the company public once again through an IPO.
Since private equity firms use a significant amount of debt and comparatively very little equity to finance transactions, anything that impacts the cost of debt or the ability to raise debt is a very sensitive consideration when considering the capital structure of a potential investment.
C Corp for Software Companies Factor Impact Investor Appeal Tax Efficiency Ownership Flexibility M&A Potential C Corps are highly attractive to investors, particularly for those considering venture capital or IPO. The flexibility to have multiple stock classes is a major draw for institutional investors.
Global Market Update - In the second half of 2024 global capital markets witnessed a gradual recovery, with IPO activity slowly rebounding from the restrained levels of early in the year. Despite this progress, deal volumes remain well below historical norms, reflecting ongoing macroeconomic.
billion kicking off 2025 with a bang, will the pounds go back on in the new year? Below we take a look at drivers of these dynamics over the past year and offer our predictions for whats to come in 2025. With J&Js announced deal to acquire Intra-Cellular Therapies for $14.6
Through additional growth, site maturation and a decreasing interest rate environment, many platforms will be in a better position to achieve an acceptable exit in 2025 and beyond. Public Markets: It is possible that a few of the car wash platforms with strong growth and financial performance pursue an initial public offering (IPO).
Jason Paltrowitz, director and EVP, corporate services, OTC Markets Group From across the pond, were bullish 2025 could be a good year for UK equities. To achieve the rewards of such optimism, UK capital markets must continue evolving, and we expect London to still face challenges around perceived attractiveness.
The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. 7] The OISP took effect on January 2, 2025. So is tech M&A back?
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content